Plain-English translation of NCT07230847 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a newer heart stent called BioFreedom™ in patients who have had a heart attack and are at higher risk of bleeding. Researchers want to compare how well BioFreedom™ stents heal compared to a standard stent (Xience), by using a special imaging camera to look inside your arteries one month after the stent is placed.
Patients at high bleeding risk often need medications after stent placement that can cause serious bleeding. This medication is designed to promote faster, safer healing while reducing clotting problems, but researchers need detailed imaging studies to confirm how well it works in this vulnerable population.
You likely qualify if…
You likely don't qualify if…
You will receive one of two types of heart stents during your procedure for the heart attack. One month after the stent is placed, you will return for a special imaging test called optical coherence tomography (OCT), which uses a tiny camera to take detailed pictures inside your artery to see how the stent is healing. The study involves this one-month follow-up visit and assessment.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
China